Durable Molecular Remission in a Lymphoid BP-CML Patient Harboring T315I Mutation Treated With Anti-Cd19 CAR-T Therapy
OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s232102
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2019
Authors
Publisher
Informa UK Limited